Abstract 274: EuReCa ONE---25 Nations, ONE Europe, ONE Registry: A Prospective Data Analysis Over 1 Month in 25 Resuscitation Registries in Europe
Background and Objectives: Cardiovascular disease is the leading cause of death throughout Europe. There is considerable variation in the incidence of out-of-hospital cardiac arrest (OHCA) between European countries and communities and the incidence of resuscitation attempts also varies widely (38-86/100,000 inhabitants /year). Reasons for variation in incidence may include differences in cardiovascular disease prevalence, lifestyle and nutritional behaviour, differences in the structure and deployment of emergency medical services and variation in treatment options in receiving hospitals.
The aim of EuReCa ONE (European Registry of Cardiac arrest Trial One) is to aid understanding of the differences in incidence and outcomes from OHCA in Europe by comparing the epidemiology, treatment and survival from OHCA across 25 European countries. Predefined research questions will focus on e. g.the incidence of OHCA throughout Europe, the initial presenting rhythm, the rate of return of spontaneous circulation (ROSC rate) and 30-day survival.
The study is governed by a Steering Group from the European Resuscitation Council and is administered and conducted by a European study management team.
Methods: From 1st-31st October 2014, every patient who suffers an OHCA, and is attended and/or treated by an emergency medical service and documented in one of the participating registries will be included in the study. Patients will be included regardless of arrest aetiology, first rhythm, age or gender. The study dataset was developed in accordance with Utstein criteria and was ‘future-proofed’ to ensure data collected will be compatible with the 2014 Utstein dataset. All data will be submitted by National Coordinators in each participating country to the EuReCa One database in anonymised format.
Conclusion: The incidence and survival rates after OHCA are heterogeneous throughout Europe. This study is the starting point for a pan-European registry of OHCA that can highlight the differences in OHCA treatment and survival throughout Europe and potentially serve as a support to quality benchmarking across the continent.
Author Disclosures: J. Gräsner: Speakers Bureau; Modest; Weinmann Medical Germany. B. Böttiger: None. J. Herlitz: None. R. Koster: Research Grant; Significant; Physio Control, Redmod, WA, USA. F. Rossel Ortiz: None. I. Tjelmeland: None. J. Wnent: None. H. Maurer: None. S. Masterson: None. L. Bossaert: None.
- © 2014 by American Heart Association, Inc.